60 related articles for article (PubMed ID: 21882201)
1. Clinicopathologic variables predicting tumor response to neoadjuvant chemotherapy in patients with locally advanced gastric cancer.
Wang LB; Teng RY; Jiang ZN; Hu WX; Dong MJ; Yuan XM; Chen WJ; Jin M; Shen JG
J Surg Oncol; 2012 Mar; 105(3):293-6. PubMed ID: 21882201
[TBL] [Abstract][Full Text] [Related]
2. Pathologic Complete Response Following Neoadjuvant Therapy for Gastric Adenocarcinoma: A National Cancer Database Analysis on Incidence, Predictors, and Outcomes.
Kaltenmeier C; Althans A; Mascara M; Nassour I; Khan S; Hoehn R; Zureikat A; Tohme S
Am Surg; 2021 Jul; 87(7):1145-1154. PubMed ID: 33342268
[TBL] [Abstract][Full Text] [Related]
3. Oligometastatic gastric cancer: An emerging clinical entity with distinct therapeutic implications.
Salati M; Valeri N; Spallanzani A; Braconi C; Cascinu S
Eur J Surg Oncol; 2019 Aug; 45(8):1479-1482. PubMed ID: 30448343
[TBL] [Abstract][Full Text] [Related]
4. Imaging lymph node regression can predict the pathological tumor regression grade in gastric cancer after neoadjuvant treatment.
Meng F; Yang Y; Wang X; Cai F; Liang H; Zhang R; Deng J
Surgery; 2023 Oct; 174(4):836-843. PubMed ID: 37562986
[TBL] [Abstract][Full Text] [Related]
5. [Regarding the selection of individualized therapy after neoadjuvant therapy for gastrointestinal tumors].
Zhai JN; Lei XK; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):338-347. PubMed ID: 38644238
[TBL] [Abstract][Full Text] [Related]
6. Expression of concern: "Patient-derived organoids from locally advanced gastric adenocarcinomas can predict resistance to neoadjuvant chemotherapy" [J Gastrointest Surg. 2023 Apr;27(4):666-76].
J Gastrointest Surg; 2024 Jun; 28(6):1008. PubMed ID: 38839209
[No Abstract] [Full Text] [Related]
7. Impact of pathologic tumor response in the treatment of gastric cancer.
Wong J
Transl Gastroenterol Hepatol; 2016; 1():71. PubMed ID: 28138637
[No Abstract] [Full Text] [Related]
8. Development of a clinical nomogram for prediction of response to neoadjuvant chemotherapy in patients with advanced gastric cancer.
Liu B; Xu YJ; Chu FR; Sun G; Zhao GD; Wang SZ
World J Gastrointest Surg; 2024 Feb; 16(2):396-408. PubMed ID: 38463346
[TBL] [Abstract][Full Text] [Related]
9. Is Pathologic Complete Response a Good Predictor for the Long-Term, Clinical Outcome in Patients with Gastric Cancer After Neoadjuvant Chemotherapy? A Retrospective, Multi-institution Study in China.
Lin C; Ma J; Zhu C; Zhao X; Chen Y; Zang L; Liu F
Ann Surg Oncol; 2023 Sep; 30(9):5534-5542. PubMed ID: 37332025
[TBL] [Abstract][Full Text] [Related]
10. Response Evaluation after Neoadjuvant Chemotherapy for Resectable Gastric Cancer.
Sandø AD; Fougner R; Røyset ES; Dai HY; Grønbech JE; Bringeland EA
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190246
[TBL] [Abstract][Full Text] [Related]
11. Increased CD4/CD8 Lymphocyte ratio predicts favourable neoadjuvant treatment response in gastric cancer: A prospective pilot study.
Skubleny D; Lin A; Garg S; McLean R; McCall M; Ghosh S; Spratlin JL; Schiller D; Rayat G
World J Gastrointest Oncol; 2023 Feb; 15(2):303-317. PubMed ID: 36908322
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant Chemotherapy
Xu W; Wang L; Yan C; He C; Lu S; Ni Z; Hua Z; Zhu Z; Sah BK; Yang Z; Zheng Y; Feng R; Li C; Yao X; Chen M; Liu W; Yan M; Zhu Z
Front Oncol; 2021; 11():718556. PubMed ID: 34497768
[TBL] [Abstract][Full Text] [Related]
13. High GP73 Expression Correlates with Poor Response to Neoadjuvant Chemotherapy and Survival in Gastric Cancer: A Tissue Microarray Study.
Shen JG; Shen J; Teng RY; Wang LB; Zhao WH; Wang QC
Pathol Oncol Res; 2021; 27():603838. PubMed ID: 34257562
[TBL] [Abstract][Full Text] [Related]
14. A Machine Learning Model for Predicting a Major Response to Neoadjuvant Chemotherapy in Advanced Gastric Cancer.
Chen Y; Wei K; Liu D; Xiang J; Wang G; Meng X; Peng J
Front Oncol; 2021; 11():675458. PubMed ID: 34141620
[TBL] [Abstract][Full Text] [Related]
15. Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy.
Xu W; Ma Q; Wang L; He C; Lu S; Ni Z; Hua Z; Zhu Z; Yang Z; Zheng Y; Feng R; Yan C; Li C; Yao X; Chen M; Liu W; Yan M; Zhu Z
Front Oncol; 2021; 11():607640. PubMed ID: 33937020
[TBL] [Abstract][Full Text] [Related]
16. Prediction model of objective response after neoadjuvant chemotherapy in patients with locally advanced gastric cancer.
Xu W; Fan Z; Wang L; He C; Ni Z; Hua Z; Zhu Z; Yang Z; Zheng Y; Feng R; Yan C; Li C; Yao X; Chen M; Yan M; Zhu Z; Liu W
Am J Transl Res; 2021; 13(3):1568-1579. PubMed ID: 33841680
[TBL] [Abstract][Full Text] [Related]
17. Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer.
Chen YH; Xiao J; Chen XJ; Wang HS; Liu D; Xiang J; Peng JS
World J Gastroenterol; 2020 May; 26(19):2427-2439. PubMed ID: 32476803
[TBL] [Abstract][Full Text] [Related]
18. AKR1B10 expression predicts response of gastric cancer to neoadjuvant chemotherapy.
Ahmed SMU; Jiang ZN; Zheng ZH; Li Y; Wang XJ; Tang X
Oncol Lett; 2019 Jan; 17(1):773-780. PubMed ID: 30655829
[TBL] [Abstract][Full Text] [Related]
19. Correlation of pathological complete response with survival after neoadjuvant chemotherapy in gastric or gastroesophageal junction cancer treated with radical surgery: A meta-analysis.
Li Z; Shan F; Wang Y; Zhang Y; Zhang L; Li S; Jia Y; Xue K; Miao R; Li Z; Ji J
PLoS One; 2018; 13(1):e0189294. PubMed ID: 29370182
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment platelet-to-lymphocyte ratio is associated with the response to first-line chemotherapy and survival in patients with metastatic gastric cancer.
Wang J; Qu J; Li Z; Che X; Liu J; Teng Y; Jin B; Zhao M; Liu Y; Qu X
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28238215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
